News archive

Imagined ugliness, or body dysmorphic disorder (BDD) as it is known, can be treated with internet-based CBT, according to a recent randomised study, the first of its kind ever conducted. The new treatment, which is published in the British Medical Journal, has been developed by researchers at Karolinska Institutet and has the potential to increase access to care for sufferers of BDD.

Ferring Pharmaceuticals and Karolinska Institutet announce today that a collaboration agreement has been signed for the establishment of a research center exploiting the human microbiome. The programme will be fully funded by Ferring Pharmaceuticals and governed by a joint steering committee.

A gene that is often lost in childhood cancer plays an important role in the decision between life and death of certain cells, according to a new study published in the journal Developmental Cell. Researchers at Karolinska Institutet and Ludwig Cancer Research in Sweden have discovered the process by which that gene, KIF1B-β, kills cells and thereby suppresses tumour development.

This spring the first version of the mHealth service tRAppen will be released. It is hoped that it will provide patients with better opportunity to take responsibility for and affect their health positively. The development of tRAppen is described in a thesis who Åsa Revenäs, physiotherapist and PhD at the Division of Physiotherapy, defended on the 5th of February 2016.

Researchers at Karolinska Institutet have identified for the first time a cell type in the brain of mice that is integral to attention. By manipulating the activity of this cell type, the scientists were able to enhance attention in mice. The results, which are published in the journal Cell, add to the understanding of how the brain’s frontal lobes work and control behaviour.

Paolo Parini is a researcher in cardiometabolic diseases and senior Physician at Endocrinology Clinic. Since September 2015 his professorship is shared between Department of Medicine, Huddinge and Department of Laboratory Medicine.

In recent decades much hope was based on the development of personalised drug treatments, in which genetic tests determine the choice and optimal dose of medication for each individual patient. However, the real breakthrough is still to be seen, and now researchers at Karolinska Institutet show in two separate scientific papers that many more gene variants affect how a person responds to medication than previously thought – and thus that today’s analytical tools are too coarse.

The number of articles citing the lyrics of Bob Dylan in the biomedical literature has increased exponentially since 1990, according to a new study from Karolinska Institutet. The results are being published in the special Christmas issue of The BMJ.